Physician profile
John B Luke
NPI 1679763114
$7,432.03
in general payments reported to CMS, 2019-2025
37 companies · $1,162 in 2025
The $1,162 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $572 · 2020: $589 · 2021: $658 · 2022: $1,504 · 2023: $1,782 · 2024: $1,165 · 2025: $1,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,108.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $2,525.90 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $921.68 | 2019-2025 | Torus Stent Graft System, Endocross Device |
| Medtronic, INC. | $903.79 | 2021-2025 | Endurant Iis, Valiant Captivia, Venaseal |
| Angiodynamics, INC. | $430.67 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $343.33 | 2021-2025 | Enroute Transcarotid Neuroprotection System, General - Vascular Intervention, Varithena Administration Pack |
| Surmodics, INC. | $261.46 | 2022-2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Pounce Venous Thrombectomy System |
| Shockwave Medical, INC | $235.04 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $213.17 | 2020-2022 | |
| Kerecis Limited | $171.92 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Biom'Up France Sas | $163.33 | 2020-2021 | |
| Inari Medical, INC. | $163.30 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Truvic Medical, INC. | $135.18 | 2022 | |
| Cardiovascular Systems INC. | $108.29 | 2020 | |
| Biocompatibles, INC. | $88.88 | 2019 | |
| Smith+Nephew, INC. | $70.80 | 2021-2024 | Pico 14 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $69.82 | 2019 | |
| Avinger INC. | $61.58 | 2020-2021 | |
| Sanara Medtech INC. | $53.35 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $51.78 | 2020-2022 | |
| Solventum Corporation | $49.65 | 2025 | V.A.C.Ulta, Prevena |
| Cook Medical LLC | $47.79 | 2019-2024 | Cook |
| Lemaitre Vascular, INC. | $45.21 | 2020-2023 | Artegraft Vascular Graft |
| Becton, Dickinson and Company | $38.20 | 2023 | Venclose Maven Catheter |
| Sirtex Medical INC | $35.64 | 2025 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Medistim USA, INC. | $30.86 | 2020 | |
| Artivion, INC. | $29.56 | 2019-2024 | Vascular |
| W. L. Gore & Associates, INC. | $26.60 | 2022 | |
| Kci USA, INC. | $23.67 | 2021 | |
| Convatec INC. | $20.47 | 2024 | |
| Penumbra, INC. | $20.00 | 2019 | |
| Tactile Systems Technology INC | $16.97 | 2019 | |
| Medtronic Vascular, INC. | $15.85 | 2020 | |
| Abbott Laboratories | $14.58 | 2025 | Esprit |
| Philips North America LLC | $13.08 | 2021 | |
| Ekos Corporation | $11.91 | 2019 | |
| Reprise Biomedical, INC. | $11.09 | 2024 | Miro3d |
| Shape Memory Medical INC. | $7.63 | 2024 | Impede Embolization Plug |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Luke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.